Serbia In Vitro Diagnostic Reagent Industry Outlook 2022 - 2026

See how Serbia In Vitro Diagnostic Reagent performed compared to key markets such as the United States, Germany and the Netherlands.

Key Market Indicators

Serbian Diagnostic Reagent exports are set to reach $14 million by 2026, up from $11 million in 2021. This represents an average year-on-year growth of 3.3%. Since 2010, exports have grown by 12.8% annually. Serbia ranked 43rd in 2021, with Slovenia ahead at $11 million. Germany, the Netherlands and the UK placed second, third and fourth, respectively. Serbian Diagnostic Reagent imports are set to reach $51 million by 2026, up from $46 million in 2021. This represents an average year-on-year growth of 1.5%. Since 2010, imports have grown by 8.9% annually. Serbia ranked 64th in 2021, with Jordan ahead at $46 million. Germany, China and the Netherlands placed second, third and fourth, respectively.

Serbia In Vitro Diagnostic Reagent Market Data and Forecasts

How much will Serbia In Vitro Diagnostic Reagent Market grow to 2026?

Forecast: Import of Blood-Grouping Reagents to Serbia

Other Top Countries about In Vitro Diagnostic Reagent